Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
Hussam Alkaissi1, Karel Pacak1, Jared Rosenblum1
1National Institutes of Health, Bethesda, MD hussam.alkaissi@nih.gov.
The New England Journal of Medicine
|November 27, 2024
Abstract
No abstract available in PubMed .


